 |
adalimumab |
|---|---|
| Trade Name | Humira |
| Orphan Indication | Non-infectious intermediate, posterior, or pan-uveitis, or chronic non-infectious anterior uveitis |
| USA Market Approval | USA |
| USA Designation Date | 2014-05-13 00:00:00 |
| Sponsor | AbbVie, Inc.;1 North Waukegan Road;North Chicago, Illinois, 60064 |
